Frank E. Thomas, Director of Spero Therapeutics SPRO, has filed 2 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $25K. The latest trade was on 06/23.

FT

FT

Frank E. Thomas

Director

Company

Spero Therapeutics SPRO

First filing

23/02/13

Trades

28 trades

Buys / sales

2 / 0

12-month net buying

$25K

Last trade

06/23

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Larimar TherapeuticsLRMR	Open-market buy	02/27	03/02	5,000 sh	$5.00	$25,000	+250.0%
Larimar TherapeuticsLRMR	Open-market buy	24/02/14	24/02/15	2,000 sh	$11.00	$22,000	No record